Articles tagged "Azathioprine"

2020 American Transplant Congress
Mycophenolate Mofetil and the Incidence of Skin Cancer in Kidney Transplant Recipients
S. J. Yusuf¹, H. Bheemreddy¹, A. Imtiaz², N. Krishnan³
¹Faculty of Health and Life Sciences, Coventry University, Coventry, United Kingdom, ²Dermatology, University Hospital Coventry and Warwickshire NHS Trust, Coventry, United Kingdom, ³Renal Unit, University Hospital Coventry and Warwickshire NHS Trust, Coventry, United Kingdom
*Purpose: Over the years there has been a shift in the use of anti-metabolites agents from azathioprine to mycophenolate mofetil (MMF) based immunosuppression., due to…
2019 American Transplant Congress
Mycophenolate Mofetil versus Azathioprine in Kidney Transplant Recipients on Steroid-Free Low-Dose Cyclosporine Immunosuppression: The ATHENA Trial
P. Cravedi¹, P. Ruggenenti², E. Gotti², A. Plati², S. Sandrini³, N. Bossini³, F. Citterio⁴, E. Minetti⁵, D. Montanaro⁶, R. Tardanico³, E. Sabadini², F. Gaspari⁷, A. Villa⁷, F. Peraro⁷, G. Remuzzi⁷
¹Mount Sinai, New York, NY, ²ASST Ospedale Papa Giovanni XXIII, Bergamo, Italy, ³ASST degli Spedali Civili, Brescia, Italy, ⁴Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy, ⁵ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy, ⁶Presidio Ospedaliero Universitario Santa Maria della Misericordia, Udine, Italy, ⁷Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy
*Purpose: Registration trials using old sandimmune formulation of cyclosporine (CsA) led to the general idea that Mycophenolate Mofetil (MMF) prevents acute cellular rejection (ACR) more…
2015 American Transplant Congress
Short- and Long-Term Outcomes of Mycophenolate Versus Azathioprine in a Large Cohort of Renal Transplant Recipients
L. Bowman,¹ T. Horwedel,¹ J. Hagopian,¹ D. Brennan.²
¹Barnes-Jewish Hospital, St. Louis; ²Washington University School of Medicine, St. Louis.
Purpose: Early studies comparing mycophenolate mofetil (MMF) to azathioprine (AZA) post-renal transplantation demonstrated superiority of MMF over AZA for the prevention of acute rejection (AR).…